Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amodiaquine+Artesunate vs Artemether-Lumefantrine in Ghanaian Children
NCT00406146Phase 3Unknown
- Sponsor
- University of Ghana Medical School
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of amodiaquine and artesunate in Malaria (2 arms), sponsored by University of Ghana Medical School. Primary endpoint: Adequate Clinical and Parasitological Response at 28 days. Status: unknown.
02
Drugs
amodiaquineartesunate
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT00406146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00406146.